Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL001 vs Lithium Carbonate in Bipolar I Disorder
NCT07540338Phase 2Recruiting
- Sponsor
- Alzamend Neuro
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AL001 in bipolar I disorder, sponsored by Alzamend Neuro. Started May 2026; status: recruiting.
02
Drugs
AL001
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT07540338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07540338.